Independent register of U.S. FDA drug recalls · updated Oct 12, 2026
RxRecalls Get alerts

Sterility & contamination

A product that must be sterile could not be assured sterile, or was contaminated. A top reason for injectables, eye drops and IV products - loss of sterility assurance can lead to serious infections.

6,317 FDA drug recalls with this cause, newest first.

This is the single biggest cause in the register by a wide margin. It covers products that had to be sterile - injectables, eye drops, certain ointments - but could not be verified sterile, or were found contaminated during testing. Most of these recalls come from compounding pharmacies and outsourcing facilities after an FDA inspection finds gaps in how sterile products were made. Sterility failures are treated seriously because the products involved have the least room for error, going straight into the bloodstream or the eye.

Class II · Moderate risk

Eye Wash

Lack of assurance of sterility

Terminated Sterility / contamination United Exchange Corporation NDC 0904-6491-20 D-0499-2017
Class I · High risk

Eye Wash

Non-Sterility: Direct evidence of contamination for 2 lots based on FDA samples.

Terminated Sterility / contamination United Exchange Corporation NDC 0904-6491-20 D-0496-2017
Class II · Moderate risk

Phenylephrine HCI Injection

Lack of Assurance of Sterility: a recent FDA inspection at the manufacturing firm raised concerns that product sterility may be compromised.

Terminated Sterility / contamination Sandoz Inc NDC 66758-016-03 D-1514-2016
Class II · Moderate risk

Ephedrine Sulfate Injection

Lack of Assurance of Sterility: a recent FDA inspection at the manufacturing firm raised concerns that product sterility may be compromised.

Terminated Sterility / contamination Sandoz Inc NDC 66758-008-01 D-1513-2016
Class II · Moderate risk

Ephedrine Sulfate Injection

Lack of Assurance of Sterility: An FDA inspection at the facility raised concerns that product sterility was potentially impacted.

Terminated Sterility / contamination Allergy Laboratories, Inc. NDC 69053-008-02 D-1498-2016
Class II · Moderate risk

C-Pav/Phentol/Atrop/Pge1

Lack of Assurance of Sterility; sterility concerns with all injectable drug products that were made with sterilized filtered stock solutions.

Terminated Sterility / contamination Colonia Care Pharmacy D-0209-2017
Class II · Moderate risk

C-Pav/Phentol/Pge1

Lack of Assurance of Sterility; sterility concerns with all injectable drug products that were made with sterilized filtered stock solutions.

Terminated Sterility / contamination Colonia Care Pharmacy D-0208-2017